Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.

Peterse EFP, Naber SK, Daly C, Pollett A, Paszat LF, Spaander MCW, Aronson M, Gryfe R, Rabeneck L, Lansdorp-Vogelaar I, Baxter NN.

Clin Gastroenterol Hepatol. 2019 Oct 17. pii: S1542-3565(19)31165-6. doi: 10.1016/j.cgh.2019.10.021. [Epub ahead of print]

PMID:
31629885
2.

Immigration and Adherence to Cervical Cancer Screening: A Provincewide Longitudinal Matched Cohort Study Using Multistate Transitional Models.

Lee F, Paszat LF, Sutradhar R.

J Obstet Gynaecol Can. 2019 Jun;41(6):813-823. doi: 10.1016/j.jogc.2018.06.008. Epub 2018 Oct 27.

PMID:
31130182
3.

Reply.

Bielawska B, Hookey LC, Whitehead M, Paszat LF, Rabeneck L, Tinmouth J.

Gastroenterology. 2018 Jun;154(8):2279-2280. doi: 10.1053/j.gastro.2018.05.018. Epub 2018 May 8. No abstract available.

PMID:
29750910
4.

Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method.

Catomeris P, Baxter NN, Boss SC, Paszat LF, Rabeneck L, Randell E, Serenity ML, Sutradhar R, Tinmouth J.

Arch Pathol Lab Med. 2018 Jan;142(1):75-82. doi: 10.5858/arpa.2016-0294-OA. Epub 2017 Oct 2.

PMID:
28967803
5.

Anesthesia Assistance in Outpatient Colonoscopy and Risk of Aspiration Pneumonia, Bowel Perforation, and Splenic Injury.

Bielawska B, Hookey LC, Sutradhar R, Whitehead M, Xu J, Paszat LF, Rabeneck L, Tinmouth J.

Gastroenterology. 2018 Jan;154(1):77-85.e3. doi: 10.1053/j.gastro.2017.08.043. Epub 2017 Sep 1.

PMID:
28865733
6.

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.

Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I.

PLoS One. 2017 Mar 15;12(3):e0172864. doi: 10.1371/journal.pone.0172864. eCollection 2017.

7.

A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive result on a fecal occult blood test in Ontario's ColonCancerCheck program.

Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J.

Curr Oncol. 2017 Feb;24(1):47-51. doi: 10.3747/co.24.3025. Epub 2017 Feb 27.

8.

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF.

PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.

9.

The effect of surgery type on survival and recurrence in very young women with breast cancer.

Quan ML, Paszat LF, Fernandes KA, Sutradhar R, McCready DR, Rakovitch E, Warner E, Wright FC, Hodgson N, Brackstone M, Baxter NN.

J Surg Oncol. 2017 Feb;115(2):122-130. doi: 10.1002/jso.24489. Epub 2017 Jan 5.

PMID:
28054348
10.

Annual surveillance mammography after early-stage breast cancer and breast cancer mortality.

Paszat LF, Sutradhar R, Gu S, Rakovitch E.

Curr Oncol. 2016 Dec;23(6):e538-e545. doi: 10.3747/co.23.3399. Epub 2016 Dec 21.

11.

Multistate transitional models for measuring adherence to breast cancer screening: A population-based longitudinal cohort study with over two million women.

Sutradhar R, Gu S, Paszat LF.

J Med Screen. 2017 Jun;24(2):75-82. doi: 10.1177/0969141316654940. Epub 2016 Jul 19.

PMID:
27440758
12.

Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.

Kagedan DJ, Abraham L, Goyert N, Li Q, Paszat LF, Kiss A, Earle CC, Mittmann N, Coburn NG.

Cancer. 2016 Oct 15;122(20):3175-3182. doi: 10.1002/cncr.30148. Epub 2016 Jul 8.

13.

Colorectal cancer mortality reduction is associated with having at least 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age.

Stock D, Paszat LF, Rabeneck L.

Gastrointest Endosc. 2016 Jul;84(1):133-41. doi: 10.1016/j.gie.2015.12.035. Epub 2016 Jan 6.

PMID:
26769406
14.

Evaluation of a clinical risk index for advanced colorectal neoplasia among a North American population of screening age.

Ruco A, Stock D, Hilsden RJ, McGregor SE, Paszat LF, Saskin R, Rabeneck L.

BMC Gastroenterol. 2015 Nov 19;15:162. doi: 10.1186/s12876-015-0395-y.

15.

Repeat colonoscopy after a colonoscopy with a negative result in Ontario: a population-based cohort study.

Hol L, Sutradhar R, Gu S, Baxter NN, Rabeneck L, Tinmouth JM, Paszat LF; investigators of the Ontario Cancer Screening Research Network.

CMAJ Open. 2015 Apr 2;3(2):E244-50. doi: 10.9778/cmajo.20140063. eCollection 2015 Apr-Jun.

16.

The association between visiting a primary care provider and uptake of periodic mammograms as women get older.

Sutradhar R, Gu S, Glazier RH, Paszat LF; investigators of the Ontario Cancer Screening Research Network.

J Med Screen. 2016 Jun;23(2):83-8. doi: 10.1177/0969141315600004. Epub 2015 Sep 9.

PMID:
26355038
17.

Patterns of diagnostic imaging and associated radiation exposure among long-term survivors of young adult cancer: a population-based cohort study.

Daly C, Urbach DR, Stukel TA, Nathan PC, Deitel W, Paszat LF, Wilton AS, Baxter NN.

BMC Cancer. 2015 Sep 3;15:612. doi: 10.1186/s12885-015-1578-1.

18.

Hospitalization Rates Among Survivors of Young Adult Malignancies.

Richardson DP, Daly C, Sutradhar R, Paszat LF, Wilton AS, Rabeneck L, Baxter NN.

J Clin Oncol. 2015 Aug 20;33(24):2655-9. doi: 10.1200/JCO.2014.60.1914. Epub 2015 Jul 13.

PMID:
26169617
19.

Organized breast screening improves reattendance compared to physician referral: a case control study.

Makedonov I, Gu S, Paszat LF; investigators of Ontario Cancer Screening Research Network.

BMC Cancer. 2015 Apr 26;15:315. doi: 10.1186/s12885-015-1346-2.

20.

Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.

Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J.

Prev Med. 2015 Jul;76:115-22. doi: 10.1016/j.ypmed.2015.03.028. Epub 2015 Apr 18.

PMID:
25895843
21.

Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program.

Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J.

Implement Sci. 2015 Mar 13;10:35. doi: 10.1186/s13012-015-0226-0.

22.

Evaluation of a risk index for advanced proximal neoplasia of the colon.

Ruco A, Stock D, Hilsden RJ, McGregor SE, Paszat LF, Saskin R, Rabeneck L.

Gastrointest Endosc. 2015;81(6):1427-32. doi: 10.1016/j.gie.2014.12.028. Epub 2015 Mar 11.

PMID:
25771065
23.

Population-based assessment of the outcomes in patients with postcolonoscopy colorectal cancers.

Govindarajan A, Rabeneck L, Yun L, Tinmouth J, Paszat LF, Baxter NN.

Gut. 2016 Jun;65(6):971-6. doi: 10.1136/gutjnl-2014-308578. Epub 2015 Mar 6.

PMID:
25748649
24.

The impact of stratifying by family history in colorectal cancer screening programs.

Goede SL, Rabeneck L, Lansdorp-Vogelaar I, Zauber AG, Paszat LF, Hoch JS, Yong JH, van Hees F, Tinmouth J, van Ballegooijen M.

Int J Cancer. 2015 Sep 1;137(5):1119-27. doi: 10.1002/ijc.29473. Epub 2015 Feb 20.

25.

Personal navigation increases colorectal cancer screening uptake.

Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):506-11. doi: 10.1158/1055-9965.EPI-14-0744. Epub 2014 Nov 6.

26.

Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario.

Honein-AbouHaidar GN, Rabeneck L, Paszat LF, Sutradhar R, Tinmouth J, Baxter NN.

BMC Cancer. 2014 Jul 25;14:537. doi: 10.1186/1471-2407-14-537.

27.

Sessile serrated polyps at screening colonoscopy: have they been under diagnosed?

Tinmouth J, Henry P, Hsieh E, Baxter NN, Hilsden RJ, Elizabeth McGregor S, Paszat LF, Ruco A, Saskin R, Schell AJ, Torlakovic EE, Rabeneck L.

Am J Gastroenterol. 2014 Nov;109(11):1698-704. doi: 10.1038/ajg.2014.78. Epub 2014 Jul 8.

PMID:
25001254
28.

Advanced proximal neoplasia of the colon in average-risk adults.

Rabeneck L, Paszat LF, Hilsden RJ, McGregor SE, Hsieh E, M Tinmouth J, Baxter NN, Saskin R, Ruco A, Stock D.

Gastrointest Endosc. 2014 Oct;80(4):660-667. doi: 10.1016/j.gie.2014.02.001. Epub 2014 Mar 27.

PMID:
24679656
29.

Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.

Tinmouth J, Baxter NN, Paszat LF, Rabeneck L, Sutradhar R, Yun L.

BMJ Open. 2014 Mar 12;4(3):e004494. doi: 10.1136/bmjopen-2013-004494.

30.

Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.

Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):508-15. doi: 10.1158/1055-9965.EPI-13-0956. Epub 2014 Jan 17.

31.

ColonCancerCheck primary care invitation pilot project: patient perceptions.

Tinmouth J, Ritvo P, McGregor SE, Patel J, Guglietti C, Levitt CA, Paszat LF, Rabeneck L.

Can Fam Physician. 2013 Dec;59(12):e541-9.

32.

Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods.

Borkhoff CM, Saskin R, Rabeneck L, Baxter NN, Liu Y, Tinmouth J, Paszat LF.

Can J Public Health. 2013 Jun 21;104(4):e284-90.

PMID:
24044467
33.

Open-access colonoscopy on Ontario: associated factors and quality.

Hadlock S, Rabeneck L, Paszat LF, Sutradhar R, Wilton AS, Tinmouth J.

Can J Gastroenterol. 2013 Jun;27(6):341-6.

34.

A population-based study of rates of childbirth in recurrence-free female young adult survivors of non-gynecologic malignancies.

Baxter NN, Sutradhar R, DelGuidice ME, Forbes S, Paszat LF, Wilton AS, Urbach D, Rabeneck L.

BMC Cancer. 2013 Jan 23;13:30. doi: 10.1186/1471-2407-13-30.

35.

ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions.

Tinmouth J, Ritvo P, McGregor SE, Guglietti C, Green J, Claus D, Levitt C, Paszat LF, Rabeneck L.

Can Fam Physician. 2012 Oct;58(10):e570-7.

36.

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Sørensen HT, Berger BM, Lidgard GP.

Gastroenterology. 2012 Feb;142(2):248-56; quiz e25-6. doi: 10.1053/j.gastro.2011.10.031. Epub 2011 Nov 4.

37.

Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer.

Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, Joy AA, Provencher L, Rayson D, Rheaume DE, Porter GA, Paszat LF, Pritchard KI, Robidoux A, Smith S, Sussman J, Dent S, Sisler J, Wiernikowski J, Levine MN.

J Clin Oncol. 2011 Dec 20;29(36):4755-62. doi: 10.1200/JCO.2011.36.8373. Epub 2011 Oct 31.

PMID:
22042959
38.

Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy.

McGregor SE, Ritvo P, Tinmouth J, Kornblum A, Myers R, Hilsden RJ, Paszat LF, Rabeneck L.

Can J Gastroenterol. 2011 May;25(5):248-52.

39.

A qualitative evaluation of strategies to increase colorectal cancer screening uptake.

Tinmouth J, Ritvo P, McGregor SE, Claus D, Pasut G, Myers RE, Guglietti C, Paszat LF, Hilsden RJ, Rabeneck L.

Can Fam Physician. 2011 Jan;57(1):e7-15.

40.

Onset and clinical course of bleeding and perforation after outpatient colonoscopy: a population-based study.

Rabeneck L, Saskin R, Paszat LF.

Gastrointest Endosc. 2011 Mar;73(3):520-3. doi: 10.1016/j.gie.2010.10.034. Epub 2010 Dec 31.

PMID:
21195406
41.

Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer.

Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L.

Gastroenterology. 2011 Jan;140(1):65-72. doi: 10.1053/j.gastro.2010.09.006. Epub 2010 Sep 18.

PMID:
20854818
42.

Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review.

Hong NJ, Wright FC, Gagliardi AR, Paszat LF.

J Surg Oncol. 2010 Aug 1;102(2):125-34. doi: 10.1002/jso.21589. Review.

PMID:
20648582
43.

Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation.

Look Hong NJ, Gagliardi AR, Bronskill SE, Paszat LF, Wright FC.

J Oncol Pract. 2010 Mar;6(2):61-8. doi: 10.1200/JOP.091085.

44.

Long-term survival in young adults with colorectal cancer: a population-based study.

Forbes SS, Sutradhar R, Paszat LF, Rabeneck L, Urbach DR, Baxter NN.

Dis Colon Rectum. 2010 Jul;53(7):973-8. doi: 10.1007/DCR.0b013e3181cf8341.

PMID:
20551747
45.

Circumstances in which colonoscopy misses cancer.

Rabeneck L, Paszat LF.

Frontline Gastroenterol. 2010 Apr;1(1):52-58. doi: 10.1136/fg.2009.000257. Epub 2010 Apr 1. Review.

46.

Association between colonoscopy rates and colorectal cancer mortality.

Rabeneck L, Paszat LF, Saskin R, Stukel TA.

Am J Gastroenterol. 2010 Jul;105(7):1627-32. doi: 10.1038/ajg.2010.83. Epub 2010 Mar 2.

PMID:
20197758
47.

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, Paszat LF.

BMJ. 2010 Feb 8;340:c693. doi: 10.1136/bmj.c693.

48.

Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy.

Rabeneck L, Paszat LF, Saskin R.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):275-9. doi: 10.1016/j.cgh.2009.10.022. Epub 2009 Oct 29.

PMID:
19879970
49.

A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist.

Alharbi O, Rabeneck L, Paszat LF, Wijeysundera DN, Sutradhar R, Yun L, Vinden CM, Tinmouth J.

Anesthesiology. 2009 Oct;111(4):734-40. doi: 10.1097/ALN.0b013e3181b786d4.

PMID:
19741486
50.

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF.

J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923. Epub 2009 Jun 8.

Supplemental Content

Loading ...
Support Center